23andMe Cuts 40% Of Workforce, Discontinues Drug Development

23andMe (Shutterstock)
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Strategy

More from HBW Insight